The Union Health Ministry India has launched a nationwide mass drug administration (MDA) campaign aimed at ending filariasis disease transmission through door-to-door administration of anti-filarial drugs, especially in 10 affected states on 10 Feb 2023.
India has ramped up efforts to eliminate lymphatic filariasis (LF), a vector-borne disease caused by culex mosquitoes that leads to disabilities, well ahead of the global targets to safeguard communities from disabilities, as well as from social and economic insecurity. The government of India has already unveiled a renewed five-pronged strategy for the elimination of LF.
Brugia Rapid point-of-care test manufactured by Reszon is recommended by WHO for use during Transmission Assessment Surveys (TAS) in several endemic countries such as Malaysia, Indonesia, Phillipines, Vietnam and Sri Lanka to detect IgG4 antibody against Brugia spp. in human blood samples. Through the use of our product as diagnostic tool, we hope that the correct intervention can be administered and hence helping to stop the spread of filariasis infection in the affected countries.
Learn more on Brugia Rapid now!
Reference:
1. PTI (11 Feb 2023) Health Ministry Launches Nationwide Campaign to Combat Filariasis. Outlook Publishing (India) Pvt. Ltd. Accessed on 13 Feb 2023
2. IANS (11 Feb 2023) Mass Drug Administration campaign launched to eliminate lymphatic filariasis. ETHealthworld.com. Accessed on 13 Feb 2023
